N/A
Completed N=60
The Association Between Endometriosis, Obesity and nesfatin1
Source: ClinicalTrials.gov NCT02683954 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Apr 2016
Primary outcomePrimary: Serum Nesfatin 1 — 190; 510 picogram/millilitre — p=0.05
Summary
The association between endometriosis, obesity and nesfatin1.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Serum Nesfatin 1 |
190; 510 | 0.05 |
Eligibility Criteria
Inclusion Criteria
- Women in reproductive age group scheduled for laparoscopy for any indication.
Exclusion Criteria
- Women subject to any hormonal therapy in the last 3 months.
- Women with chronic endocrine disease like diabetes mellitus.
- Women diagnosed with pelvic inflammatory disease (PID).
- Severe medical disorder that prohibits the laparoscopic procedure, such as cardiovascular disease and pulmonary disease.
Data sourced from ClinicalTrials.gov (NCT02683954). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.